A woman of 46 noticed a painful mass 4 cm proximal to the medial epicondyle of her right arm; there was no history of trauma or infection. The mass was 36462 cm when measured clinically and did not involve the skin or underlying musculature. There were no signs of acute infection, lymphangitis or axillary lymphadenopathy and the white blood cell count was normal. Magnetic resonance imaging showed a 663 cm encapsulated tumour super®cial to the fascia (Figure 1 ) and seeming to involve the epifascial veins. On surgical exploration it proved to be an encapsulated abscess, histologically a vascular in¯ammatory granuloma. Special staining excluded typical and atypical mycobacteria. Warthin±Starry silver staining revealed aggregates of Gram-negative bacteria characteristic of Bartonella henselae infection ( Figure 2 ). IgG antibodies to Bartonella, measured by an indirect immuno¯uorescence assay, rose postoperatively from normal (51:64) to 41:512, con®rming the diagnosis. The patient's history was re-evaluated. She had recently acquired a one-year-old cat and had noticed a red papule on the skin of her right hand 3 1 ¤ 2 weeks before the onset of the painful swelling in her elbow which was still present as hyperpigmentation 6 weeks later ( Figure 3 ). She also mentioned an episode with headache and general fatigue without fever, after the appearance of the papule. Her postoperative course was uneventful.
COMMENT
In 1889, Parinaud reported an oculoglandular syndrome of lymphadenopathy and conjunctivitis that is now known as cat-scratch disease (CSD). In 1950, Debre Â et al. 1 described the relationship of adenopathy and house-cat contact. Several genetically related organisms have been implicated in the aetiology. Initially, A®pia felis was believed to be the causal agent. Subsequently, Rochalimaea species were associated with an immune response in patients with CSD. These were renamed as Bartonella in view of extensive 16S rRNA sequence homology with organisms in this genus 2 . Recently B. henselae has been identi®ed as a major cause for CSD 1,2 . Cats may infect humans either directly through scratches, bites or licks, or indirectly via an arthropod vector. The cutaneous lesion is typically a round, redbrown, nontender papule that develops one week after contact with a cat, most often a newly acquired kitten. This minor injury often goes unrecognized. In the next 1±2 weeks regional lymph nodes that drain the area gradually enlarge to several centimetres over 2±3 weeks and may stay for another 3 weeks 3 . Some cases are more severe and last several months; many others go undiagnosed. In about 10% of patients the nodes become infected and suppurate. The lymph nodes most often involved are in the axilla, then the neck and jaw region and the groin 3 .
Epitrochlear swellings, as seen in our patient, are infrequent. Early in the course of infection lymph nodes show hyperplasia with vascular proliferation. As the infection progresses granulomas appear, and later multiple microabscesses form, fusing to larger abscesses in those nodes that undergo suppuration. Gram-negative, argyrophilic, non-acid-fast, pleomorphic bacilli may be seen in lymph node preparations or may be noted on biopsy of the primary papules. Usually there is a local in¯ammation of the involved lymph node and not an encapsulated abscess as in our patient. The course of CSD, however, is usually benign and often selfresolving. Malaise, headache, and fever occur in fewer than half the patients 3 .
In the past, histopathological examination of the involved lymph node specimens was thought to be the most reliable diagnostic test for CSD. Typical ®ndings include stellate caseating granulomas, microabscesses, and lymphoid follicular hyperplasia. Histological examination with Warthin±Starry silver stain or Brown±Hopps tissue Gram stain, with electron microscopy or immuno¯uorescence, reveals argyrophilic aggregates of bacteria 4 . However, the tissue stains do not distinguish between species of Bartonella. Although B. henselae organisms can technically be cultured from specimens of tissue or blood, incubation for up to 6 weeks is required 1±3 .
Serological testing for the presence of antibodies to B. henselae is the most widely used test for con®rmation of diagnosis. An indirect¯uorescent antibody technique is at present the most effective test, with up to 93% sensitivity and 98% speci®city in selected populations 5 ; the most sensitive test is a polymerase chain reaction to detect the presence of B. henselae-speci®c DNA sequences 6 , but it is not widely available and the quality may vary between laboratories.
Cat-scratch disease is most often seen in children or in association with human immunode®ciency virus infection. It is usually unresponsive to antibiotics, even when the organism is sensitive in vitro. Whereas healthy individuals tend to recover spontaneously, immunocompromised patients are at risk of progressive and fatal infections. The most effective antibiotics seem to be erythromycin, rifampicin, doxycycline and gentamicin 2±4 . In occasional patients with low adrenal cortical or thyroid function, the main symptoms are musculoskeletal 1,2 . Indeed, when the features are those of a myopathy, the patient is likely to be seen ®rst by a neurologist rather than an endocrinologist, as happened in the following two cases.
CASE HISTORIES

Case 1
A boy of 13 was admitted with a 2-year history of muscle cramps. Serum creatine kinase was 270 U/L (reference range 25±200). Electromyographic ®ndings were normal but muscle biopsy (vastus lateralis) showed atrophic ®bres and intermediate type 2c ®bres. Because of recent episodes suggestive of postural hypotension the endocrine evaluation focused on possible adrenal cortical hypofunction. Serum cortisol was very low at 95 nmol/L (reference range 160±580), plasma aldosterone was slightly depressed at 48 pmol/L (56±360) and serum corticotropin was very high at 35.6 pmol/L (2.2±13.3). Adrenal cortex antibody was present in a titre of 1:16. Addison's disease was diagnosed and he was started on cortisone acetate 37.5 mg/day and udrocortisone 50±100 mg/day. After several months' treatment the muscle cramps were no better and the patient was re-evaluated. He proved to have primary hypothyroidism in addition to the adrenal failureÐfree thyroxine (FT4) 12 pmol/L (reference range 11.7±24.6), basal thyrotropin (TSH) 6 mU/L (0.23±4.0), TRHstimulated TSH 40 mU/L (5±25). Thyroid microsomal antibodies were present at 1:400; thyroglobulin antibody was not detected. On sonography the thyroid gland was atrophic. When L-thyroxine 100 mg/day was added to the steroid replacement therapy, the cramps disappeared.
Case 2
A bricklayer aged 45 was admitted with a 5-year history of asthenia, myalgias and cramps in the legs; lately his symptoms had included poor memory and apathy, and vitiligo had appeared. At the age of 35 he had been investigated for similar symptoms and Hashimoto's thyroiditis had been diagnosed, on the basis of a high TSH and positive thyroglobulin and thyroid microsomal antibodies. Taking L-thyroxine 100 mg/day he had then been well for 5 years. Thereafter the symptoms had returned, and in subsequent years evaluations by internists, orthopaedic surgeons, neurologists and psychologists had been unrewarding. Seemingly the possibility of adrenal failure had been considered, because serum cortisol was measured on one occasion, but the result had been normal (233 mmol/L, reference range 193±666).
When referred to us the patient had no abnormal physical signs; blood pressure was 95/60 mmHg. Findings on electromyography and muscle biopsy (vastus lateralis) were normal. Serum creatine kinase was slightly raised at 209 U/L and serum potassium was 5.0±5.3. Morning serum cortisol¯uctuated from low-normal 152 mmol/L to normal and responded normally to 250 mg intravenous tetracosactrin with a peak of 588 mmol/L. Adrenal cortex antibodies were present at a titre of 1:64. As well as thyroid microsomal antibody, thyroglobulin and thyroid peroxidase antibodies were positive. We diagnosed polyglandular autoimmune syndrome type II (PGA±II) and added oral cortisone acetate (37.5 mg/day) to the thyroxine therapy. However, the patient did not improve. Therefore we asked him to stop all treatment for 8 weeks and re-evaluated him. We con®rmed the primary hypothyroidism (basal TSH 4.3 mU/L; TRH-stimulated TSH 35 mU/L) and borderline hypocortisolism (baseline 150±179 nmol/L; peak after tetracosactrin 560). We also found frank hyperreninaemic 
